Ciprofloxacin vs placebo added to cycled and culture‐based inhaled tobramycin (TNS) therapy: Eradication of P aeruginosa from the respiratory tract: proportion of participants with one or more isolates of P aeruginosa from the respiratory tract
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Ciprofloxacin vs placebo added to cycled and culture‐based inhaled tobramycin (TNS) therapy Eradication of P aeruginosa from the respiratory tract: proportion of participants with one or more isolates of P aeruginosa from the respiratory tract · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory… The review found no eligible studies for this question. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis (2023) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Ciprofloxacin vs placebo added to cycled and culture‐based inhaled tobramycin therapy Eradication of P aeruginosa from the respiratory tract: proportion of participants with one or more isolates of P aeruginosa from the respiratory tract · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory… Ciprofloxacin showed no clear difference in eradication of P aeruginosa from the respiratory tract: proportion… compared with placebo added to cycled and culture‐based inhaled tobramycin therapy (moderate certainty). Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis (2017) · Cochrane Headline outcomes onlyearlier version CD004197.PUB5, superseded | OR 0.89 [0.55, 1.44] | 1 study · 2981 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis 2023 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.